Zelegent

About Zelegent

Zelegent, Inc. specializes in providing innovative, minimally invasive treatments for snoring and obstructive sleep apnea. The company's flagship product, Elevoplasty, is a quick, in-office procedure that lifts the soft palate to address the root cause of snoring. This procedure takes approximately 10 minutes and requires no downtime, making it a convenient option for patients. Zelegent operates in the healthcare market, primarily serving patients suffering from snoring and sleep apnea. The business model is based on selling its medical devices and technology to healthcare providers and clinics, who then offer the treatment to their patients. Revenue is generated through the sale of these devices and through strategic partnerships, such as the sales and marketing agreement with Cook Medical. Zelegent has also expanded its product pipeline by acquiring the MISH Technology Platform, which allows for the development of additional products targeting obstructive sleep apnea. This positions Zelegent as a key player in the sleep disorder treatment market, providing effective and efficient solutions for a common healthcare challenge.